NCT06700928

Attentional Focus Training in Older Adults

Completed NA Last updated 7 April 2026

What this trial tests

NA trial testing External focus training in Geriatric Individuals in 50 participants. Completed in 1 November 2025.

Timeline

1 May 2025

Primary endpoint
1 November 2025

1 November 2025

Quick facts

Lead sponsor	Müşerref Ebru YALÇIN
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	1 May 2025
Primary completion	1 November 2025
Estimated completion	1 November 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• External focus training
• Internal focus training
• No attentional focus training

Conditions studied

• Geriatric Individuals — all drugs for Geriatric Individuals →
• Cognitive Function — all drugs for Cognitive Function →
• Physical Performance — all drugs for Physical Performance →

Sponsor

Müşerref Ebru YALÇIN

Who can join

65 and older, any sex, with Geriatric Individuals or Cognitive Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ability to walk safely and efficiently is crucial for older adults to maintain their independence and minimize the risk of falls. In healthy geriatric individuals, walking typically occurs as an automatic process involving motor skills, meaning the movement is generally performed with minimal conscious thought. However, attention can influence motor performance; a lack of focus or distraction can lead to loss of balance and increase the risk of falling during walking. The effects of attention focus on geriatric individuals remain uncertain. Therefore, this study aims to investigate the effects of different attention-focused training on physical performance and cognitive function in geriatric individuals. In this randomized controlled trial, 60 participants will be randomly assigned to four groups: the internal focus exercise group (n = 15), the external focus exercise group (n = 15), the no attention focus group (n = 15), and the control group (n = 15). The control group will consist of participants from a different institution to prevent contamination. Participants in the non-control groups will attend training sessions twice a week (approximately 40 minutes each) for 12 weeks. The experimental groups will complete a total of 24 exercise sessions. All training sessions will be conducted by an experienced physiotherapist. Pre- and post-assessments will be conducted. The sociodemographic characteristics of all participants will be assessed using a descriptive form. Participants' physical performance will be evaluated using the Short Physical Performance Battery (SPPB), the Stair Climbing Test, the Timed Up and Go Test (TUG), a static balance test (single-leg stance test), and a dynamic balance test (Berg Balance Scale). Cognitive function will be assessed using the Central Nervous System Vital Signs (CNSVS) Cognitive Performance and Attention Tests. Additionally, participants' walking will be analyzed using Kinect V2 camera-based software. The data collected from the study will be analyzed using SPSS (Statistical Program for the Social Sciences). Descriptive statistics will include frequencies, percentages, means, and standard deviations. For comparisons, the significance level (p) will be set at 0.05.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.